Next-Generation Sequencing (NGS) Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2024-2032
Description
Growth Factors of Next-generation Sequencing Market
The next-generation sequencing market size was valued at USD 8.30 billion in 2023, and the market is now projected tgrow from USD 9.29 billion in 2024 tUSD 27.55 billion by 2032, exhibiting a CAGR of 14.6% during the forecast period of 2024-2032.
The unexpected emergence of COVID-19 positively affected the next-generation sequencing market growth since the virus was easily spread. Hence there was a need tdiagnose it using next-generation sequencing instruments. It supported and pushed for faster development of the vaccines and funding for it. Scientific research related tgenomes was alslearned during this phase. It has been asserted that sustained adoption of such technologies is expected tdrive this market post-pandemic. This trend helps maintain progressive development and increasing innovation in this sector.
Developing next-generation sequencing (NGS) in the diagnostics segment is a key factor driving growth. Due tthe decrease in sequencing costs, the use of disease diagnoses such as cancer or genetic diagnostic tests has broadened. Organisations are alsbringing out new test kits and services. Government approvals and improvements in the reimbursement policies for next-generation sequencing escalate market share. The increase in chronic diseases and continuous research make the next-generation sequencing market share.
Additionally, governments are increasingly funding genome projects, boosting the next-generation sequencing (NGS) market. NGS has transformed disease diagnosis and management over the past decade. This technology plays a vital role in advancing healthcare. Global investments in genomics drive market growth. Such initiatives enhance disease research and innovation
Comprehensive Analysis of Next-generation Sequencing Market
The next-generation sequencing market and healthcare industry is rising at an exponential rate due tits market segmentation. This market expansion effectively provides a detailed regional assessments considering the dominant supply and demand forces that impact the healthcare industry. These segmentations are methodically segregated by Types, by Technology, by Application and by End-User. The type includes, Products {Instruments & Consumables} and Services. The technology includes, Sequencing By Synthesis (SBS), Nanopore Sequencing, ION Semiconductor Sequencing and Others. The application includes, Research & Applied and Clinical {Cardiovascular, Oncology, Genetic Diseases, Reproductive Health and Others}. The end- user includes, Pharmaceutical & Biotechnology Companies, Academic & Research Institutes and Others.
The North American market is recognized as the largest region for next-generation sequencing worth USD 4.60 billion in 2023. The region's dominance is amplified by robust genomics research, investment in research and development and the existence of companies. New products, services, and strategic alliances alsprovide other ways tescalate growth. The market is expected tsustain its dominance during this study. Further, innovations and collaboration will remain key tfuture developments and expansion.
The top players in the market play a crucial role in the healthcare industry assuring industrial prospectus growth and setting market standards. These players include, Illumina Inc. (U.S.), ThermFisher Scientific Inc. (U.S.), F. Hoffmann-La Roche Ltd. (Switzerland), QIAGEN (Germany), PacBi(U.S.), Oxford Nanopore Technologies (U.K.), Perkin Elmer, Inc. (U.S.) and BGI (China). These market players provide a level-playing competitive landscape.
In February 2024, IDT worked closely with Element Biosciences, Inc. tenhance NGS workflows by making them less complex.
Segmentation Table
Global Point of Care CT Imaging Systems Market Scope
Study Period 2019-2032
Base Year 2023
Forecast Period 2024-2032
Growth Rate CAGR of 14.6% from 2024-2032
Historical Period 2019-2022
Unit Value (USD Billion)
Segmentation By Type, Technology, Application, End-User and Region
By Type
Products
Instruments
Consumables
Services
By Technology
Sequencing By Synthesis (SBS)
Nanopore Sequencing
ION Semiconductor Sequencing
Others
By Application
Research & Applied
Clinical
Cardiovascular
Oncology
Genetic Diseases
Reproductive Health
By End- User
Pharmaceutical & Biotechnology Companies
Academic & Research Institutes
Others
By Region
North America (By Type, Technology, Application, End-User, and Country)
U.S.
Canada
Europe (By Type, Technology, Application, End-User, and Country/ Sub-Region)
U.K.
Germany
France
Italy
Spain
Scandinavia
Rest of Europe
Asia Pacific (By Type, Technology, Application, End-User, and Country/ Sub-Region)
China
Japan
India
Australia
Southeast Asia
Rest of the Asia Pacific
Latin America (By Type, Technology, Application, End-User, and Country/ Sub-Region)
Brazil
Mexico
Rest of Latin America
Middle East & Africa (By Type, Technology, Application, End-User, and Country/ Sub-Region)
GCC
South Africa
Rest of the Middle East & Africa
The next-generation sequencing market size was valued at USD 8.30 billion in 2023, and the market is now projected tgrow from USD 9.29 billion in 2024 tUSD 27.55 billion by 2032, exhibiting a CAGR of 14.6% during the forecast period of 2024-2032.
The unexpected emergence of COVID-19 positively affected the next-generation sequencing market growth since the virus was easily spread. Hence there was a need tdiagnose it using next-generation sequencing instruments. It supported and pushed for faster development of the vaccines and funding for it. Scientific research related tgenomes was alslearned during this phase. It has been asserted that sustained adoption of such technologies is expected tdrive this market post-pandemic. This trend helps maintain progressive development and increasing innovation in this sector.
Developing next-generation sequencing (NGS) in the diagnostics segment is a key factor driving growth. Due tthe decrease in sequencing costs, the use of disease diagnoses such as cancer or genetic diagnostic tests has broadened. Organisations are alsbringing out new test kits and services. Government approvals and improvements in the reimbursement policies for next-generation sequencing escalate market share. The increase in chronic diseases and continuous research make the next-generation sequencing market share.
Additionally, governments are increasingly funding genome projects, boosting the next-generation sequencing (NGS) market. NGS has transformed disease diagnosis and management over the past decade. This technology plays a vital role in advancing healthcare. Global investments in genomics drive market growth. Such initiatives enhance disease research and innovation
Comprehensive Analysis of Next-generation Sequencing Market
The next-generation sequencing market and healthcare industry is rising at an exponential rate due tits market segmentation. This market expansion effectively provides a detailed regional assessments considering the dominant supply and demand forces that impact the healthcare industry. These segmentations are methodically segregated by Types, by Technology, by Application and by End-User. The type includes, Products {Instruments & Consumables} and Services. The technology includes, Sequencing By Synthesis (SBS), Nanopore Sequencing, ION Semiconductor Sequencing and Others. The application includes, Research & Applied and Clinical {Cardiovascular, Oncology, Genetic Diseases, Reproductive Health and Others}. The end- user includes, Pharmaceutical & Biotechnology Companies, Academic & Research Institutes and Others.
The North American market is recognized as the largest region for next-generation sequencing worth USD 4.60 billion in 2023. The region's dominance is amplified by robust genomics research, investment in research and development and the existence of companies. New products, services, and strategic alliances alsprovide other ways tescalate growth. The market is expected tsustain its dominance during this study. Further, innovations and collaboration will remain key tfuture developments and expansion.
The top players in the market play a crucial role in the healthcare industry assuring industrial prospectus growth and setting market standards. These players include, Illumina Inc. (U.S.), ThermFisher Scientific Inc. (U.S.), F. Hoffmann-La Roche Ltd. (Switzerland), QIAGEN (Germany), PacBi(U.S.), Oxford Nanopore Technologies (U.K.), Perkin Elmer, Inc. (U.S.) and BGI (China). These market players provide a level-playing competitive landscape.
In February 2024, IDT worked closely with Element Biosciences, Inc. tenhance NGS workflows by making them less complex.
Segmentation Table
Global Point of Care CT Imaging Systems Market Scope
Study Period 2019-2032
Base Year 2023
Forecast Period 2024-2032
Growth Rate CAGR of 14.6% from 2024-2032
Historical Period 2019-2022
Unit Value (USD Billion)
Segmentation By Type, Technology, Application, End-User and Region
By Type
Products
Instruments
Consumables
Services
By Technology
Sequencing By Synthesis (SBS)
Nanopore Sequencing
ION Semiconductor Sequencing
Others
By Application
Research & Applied
Clinical
Cardiovascular
Oncology
Genetic Diseases
Reproductive Health
By End- User
Pharmaceutical & Biotechnology Companies
Academic & Research Institutes
Others
By Region
North America (By Type, Technology, Application, End-User, and Country)
U.S.
Canada
Europe (By Type, Technology, Application, End-User, and Country/ Sub-Region)
U.K.
Germany
France
Italy
Spain
Scandinavia
Rest of Europe
Asia Pacific (By Type, Technology, Application, End-User, and Country/ Sub-Region)
China
Japan
India
Australia
Southeast Asia
Rest of the Asia Pacific
Latin America (By Type, Technology, Application, End-User, and Country/ Sub-Region)
Brazil
Mexico
Rest of Latin America
Middle East & Africa (By Type, Technology, Application, End-User, and Country/ Sub-Region)
GCC
South Africa
Rest of the Middle East & Africa
Table of Contents
145 Pages
- 1. Introduction
- 1.1. Market Scope
- 1.2. Market Segmentation
- 1.3. Market Methodology
- 1.4. Definitions and Assumptions
- 2. Executive Summary
- 3. Market Dynamics
- 3.1. Market Drivers
- 3.2. Market Restraints
- 3.3. Market Opportunities
- 3.4. Market Trends
- 4. Key Insights
- 4.1. Prevalence of Key Diseases, By Key Countries, 2023
- 4.2. Overview: Regulatory Scenario & Reimbursement Scenario, By Key Countries/Region
- 4.3. New Product Launches, By Key Players
- 4.4. Key Industry Developments, By Key Players
- 4.5. Overview: Technological Advancements in Next-generation Sequencing
- 4.6. Impact of COVID-19 on the Market
- 5. Global Next-generation Sequencing Market Analysis, Insights and Forecast, 2019-2032
- 5.1. Market Analysis, Insights and Forecast - By Type
- 5.1.1. Products
- 5.1.1.1. Instruments
- 5.1.1.2. Consumables
- 5.1.2. Services
- 5.2. Market Analysis, Insights and Forecast - By Technology
- 5.2.1. Sequencing By Synthesis (SBS)
- 5.2.2. Nanopore Sequencing
- 5.2.3. ION Semiconductor Sequencing
- 5.2.4. Others
- 5.3. Market Analysis, Insights and Forecast - By Application
- 5.3.1. Research & Applied
- 5.3.2. Clinical
- 5.3.2.1. Cardiovascular
- 5.3.2.2. Oncology
- 5.3.2.3. Genetic Diseases
- 5.3.2.4. Reproductive Health
- 5.4. Market Analysis, Insights and Forecast - By End User
- 5.4.1. Pharmaceutical & Biotechnology Companies
- 5.4.2. Academic & Research Institutes
- 5.4.3. Others
- 5.5. Market Analysis, Insights and Forecast - By Region
- 5.5.1. North America
- 5.5.2. Europe
- 5.5.3. Asia Pacific
- 5.5.4. Latin America
- 5.5.5. Middle East & Africa
- 6. North America Next-generation Sequencing Market Analysis, Insights and Forecast, 2019-2032
- 6.1. Market Analysis, Insights and Forecast - By Type
- 6.1.1. Products
- 6.1.1.1. Instruments
- 6.1.1.2. Consumables
- 6.1.2. Services
- 6.2. Market Analysis, Insights and Forecast - By Technology
- 6.2.1. Sequencing By Synthesis (SBS)
- 6.2.2. Nanopore Sequencing
- 6.2.3. ION Semiconductor Sequencing
- 6.2.4. Others
- 6.3. Market Analysis, Insights and Forecast - By Application
- 6.3.1. Research & Applied
- 6.3.2. Clinical
- 6.3.2.1. Cardiovascular
- 6.3.2.2. Oncology
- 6.3.2.3. Genetic Diseases
- 6.3.2.4. Reproductive Health
- 6.4. Market Analysis, Insights and Forecast - By End User
- 6.4.1. Pharmaceutical & Biotechnology Companies
- 6.4.2. Academic & Research Institutes
- 6.4.3. Others
- 6.5. Market Analysis, Insights and Forecast - By Country
- 6.5.1. U.S.
- 6.5.2. Canada
- 7. Europe Next-generation Sequencing Market Analysis, Insights and Forecast, 2019-2032
- 7.1. Market Analysis, Insights and Forecast - By Type
- 7.1.1. Products
- 7.1.1.1. Instruments
- 7.1.1.2. Consumables
- 7.1.2. Services
- 7.2. Market Analysis, Insights and Forecast - By Technology
- 7.2.1. Sequencing By Synthesis (SBS)
- 7.2.2. Nanopore Sequencing
- 7.2.3. ION Semiconductor Sequencing
- 7.2.4. Others
- 7.3. Market Analysis, Insights and Forecast - By Application
- 7.3.1. Research & Applied
- 7.3.2. Clinical
- 7.3.2.1. Cardiovascular
- 7.3.2.2. Oncology
- 7.3.2.3. Genetic Diseases
- 7.3.2.4. Reproductive Health
- 7.4. Market Analysis, Insights and Forecast - By End User
- 7.4.1. Pharmaceutical & Biotechnology Companies
- 7.4.2. Academic & Research Institutes
- 7.4.3. Others
- 7.5. Market Analysis, Insights and Forecast - By Country/Sub-region
- 7.5.1. U.K
- 7.5.2. Germany
- 7.5.3. France
- 7.5.4. Spain
- 7.5.5. Italy
- 7.5.6. Scandinavia
- 7.5.7. Rest of Europe
- 8. Asia Pacific Next-generation Sequencing Market Analysis, Insights and Forecast, 2019-2032
- 8.1. Market Analysis, Insights and Forecast - By Type
- 8.1.1. Products
- 8.1.1.1. Instruments
- 8.1.1.2. Consumables
- 8.1.2. Services
- 8.2. Market Analysis, Insights and Forecast - By Technology
- 8.2.1. Sequencing By Synthesis (SBS)
- 8.2.2. Nanopore Sequencing
- 8.2.3. ION Semiconductor Sequencing
- 8.2.4. Others
- 8.3. Market Analysis, Insights and Forecast - By Application
- 8.3.1. Research & Applied
- 8.3.2. Clinical
- 8.3.2.1. Cardiovascular
- 8.3.2.2. Oncology
- 8.3.2.3. Genetic Diseases
- 8.3.2.4. Reproductive Health
- 8.4. Market Analysis, Insights and Forecast - By End User
- 8.4.1. Pharmaceutical & Biotechnology Companies
- 8.4.2. Academic & Research Institutes
- 8.4.3. Others
- 8.5. Market Analysis, Insights and Forecast - By Country/Sub-region
- 8.5.1. Japan
- 8.5.2. China
- 8.5.3. India
- 8.5.4. Australia
- 8.5.5. Southeast Asia
- 8.5.6. Rest of Asia Pacific
- 9. Latin America Next-generation Sequencing Market Analysis, Insights and Forecast, 2019-2032
- 9.1. Market Analysis, Insights and Forecast - By Type
- 9.1.1. Products
- 9.1.1.1. Instruments
- 9.1.1.2. Consumables
- 9.1.2. Services
- 9.2. Market Analysis, Insights and Forecast - By Technology
- 9.2.1. Sequencing By Synthesis (SBS)
- 9.2.2. Nanopore Sequencing
- 9.2.3. ION Semiconductor Sequencing
- 9.2.4. Others
- 9.3. Market Analysis, Insights and Forecast - By Application
- 9.3.1. Research & Applied
- 9.3.2. Clinical
- 9.3.2.1. Cardiovascular
- 9.3.2.2. Oncology
- 9.3.2.3. Genetic Diseases
- 9.3.2.4. Reproductive Health
- 9.4. Market Analysis, Insights and Forecast - By End User
- 9.4.1. Pharmaceutical & Biotechnology Companies
- 9.4.2. Academic & Research Institutes
- 9.4.3. Others
- 9.5. Market Analysis, Insights and Forecast - By Country/Sub-region
- 9.5.1. Brazil
- 9.5.2. Mexico
- 9.5.3. Rest of Latin America
- 10. Middle East & Africa Next-generation Sequencing Market Analysis, Insights and Forecast, 2019-2032
- 10.1. Market Analysis, Insights and Forecast - By Type
- 10.1.1. Products
- 10.1.1.1. Instruments
- 10.1.1.2. Consumables
- 10.1.2. Services
- 10.2. Market Analysis, Insights and Forecast - By Technology
- 10.2.1. Sequencing By Synthesis (SBS)
- 10.2.2. Nanopore Sequencing
- 10.2.3. ION Semiconductor Sequencing
- 10.2.4. Others
- 10.3. Market Analysis, Insights and Forecast - By Application
- 10.3.1. Research & Applied
- 10.3.2. Clinical
- 10.3.2.1. Cardiovascular
- 10.3.2.2. Oncology
- 10.3.2.3. Genetic Diseases
- 10.3.2.4. Reproductive Health
- 10.4. Market Analysis, Insights and Forecast - By End User
- 10.4.1. Pharmaceutical & Biotechnology Companies
- 10.4.2. Academic & Research Institutes
- 10.4.3. Others
- 10.5. Market Analysis, Insights and Forecast - By Country/Sub-region
- 10.5.1. GCC
- 10.5.2. South Africa
- 10.5.3. Rest of Middle East & Africa
- 11. Competitive Analysis
- 11.1. Global Market Share Analysis (2023)
- 11.2. Company Profiles
- 11.2.1. Illumina Inc.
- 11.2.1.1. Overview
- 11.2.1.2. Products & services
- 11.2.1.3. SWOT Analysis
- 11.2.1.4. Recent Developments
- 11.2.1.5. Strategies
- 11.2.1.6. Financials (Based on Availability)
- 11.2.2. Thermo Fisher Scientific Inc.
- 11.2.2.1. Overview
- 11.2.2.2. Products & services
- 11.2.2.3. SWOT Analysis
- 11.2.2.4. Recent Developments
- 11.2.2.5. Strategies
- 11.2.2.6. Financials (Based on Availability)
- 11.2.3. F. Hoffmann-La Roche Ltd.
- 11.2.3.1. Overview
- 11.2.3.2. Products & services
- 11.2.3.3. SWOT Analysis
- 11.2.3.4. Recent Developments
- 11.2.3.5. Strategies
- 11.2.3.6. Financials (Based on Availability)
- 11.2.4. QIAGEN
- 11.2.4.1. Overview
- 11.2.4.2. Products & services
- 11.2.4.3. SWOT Analysis
- 11.2.4.4. Recent Developments
- 11.2.4.5. Strategies
- 11.2.4.6. Financials (Based on Availability)
- 11.2.5. PacBio
- 11.2.5.1. Overview
- 11.2.5.2. Products & services
- 11.2.5.3. SWOT Analysis
- 11.2.5.4. Recent Developments
- 11.2.5.5. Strategies
- 11.2.5.6. Financials (Based on Availability)
- 11.2.6. Oxford Nanopore Technologies
- 11.2.6.1. Overview
- 11.2.6.2. Products & services
- 11.2.6.3. SWOT Analysis
- 11.2.6.4. Recent Developments
- 11.2.6.5. Strategies
- 11.2.6.6. Financials (Based on Availability)
- 11.2.7. Perkin Elmer, Inc.
- 11.2.7.1. Overview
- 11.2.7.2. Products & services
- 11.2.7.3. SWOT Analysis
- 11.2.7.4. Recent Developments
- 11.2.7.5. Strategies
- 11.2.7.6. Financials (Based on Availability)
- 11.2.8. BGI
- 11.2.8.1. Overview
- 11.2.8.2. Products & services
- 11.2.8.3. SWOT Analysis
- 11.2.8.4. Recent Developments
- 11.2.8.5. Strategies
- 11.2.8.6. Financials (Based on Availability) "
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
